These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 25321477)

  • 1. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.
    Coloff JL; Macintyre AN; Nichols AG; Liu T; Gallo CA; Plas DR; Rathmell JC
    Cancer Res; 2011 Aug; 71(15):5204-13. PubMed ID: 21670080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt requires glucose metabolism to suppress puma expression and prevent apoptosis of leukemic T cells.
    Coloff JL; Mason EF; Altman BJ; Gerriets VA; Liu T; Nichols AN; Zhao Y; Wofford JA; Jacobs SR; Ilkayeva O; Garrison SP; Zambetti GP; Rathmell JC
    J Biol Chem; 2011 Feb; 286(7):5921-33. PubMed ID: 21159778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
    Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J
    PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
    Caro-Maldonado A; Wang R; Nichols AG; Kuraoka M; Milasta S; Sun LD; Gavin AL; Abel ED; Kelsoe G; Green DR; Rathmell JC
    J Immunol; 2014 Apr; 192(8):3626-36. PubMed ID: 24616478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ENO2 Promotes Cell Proliferation, Glycolysis, and Glucocorticoid-Resistance in Acute Lymphoblastic Leukemia.
    Liu CC; Wang H; Wang WD; Wang L; Liu WJ; Wang JH; Geng QR; Lu Y
    Cell Physiol Biochem; 2018; 46(4):1525-1535. PubMed ID: 29689546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a synergistic combination of dimethylaminoparthenolide and shikonin alters metabolism and inhibits proliferation of pediatric precursor-B cell acute lymphoblastic leukemia.
    Sweeney SR; Collins M; Pandey R; Chiou J; Lodi A; Tiziani S
    Mol Carcinog; 2020 Apr; 59(4):399-411. PubMed ID: 32027051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia.
    Boag JM; Beesley AH; Firth MJ; Freitas JR; Ford J; Hoffmann K; Cummings AJ; de Klerk NH; Kees UR
    Leukemia; 2006 Oct; 20(10):1731-7. PubMed ID: 17041637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
    Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATM inhibitor KU-55933 induces apoptosis and inhibits motility by blocking GLUT1-mediated glucose uptake in aggressive cancer cells with sustained activation of Akt.
    Harris BRE; Zhang Y; Tao J; Shen R; Zhao X; Cleary MP; Wang T; Yang DQ
    FASEB J; 2021 Apr; 35(4):e21264. PubMed ID: 33715230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
    Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
    Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition.
    Brandi J; Cecconi D; Cordani M; Torrens-Mas M; Pacchiana R; Dalla Pozza E; Butera G; Manfredi M; Marengo E; Oliver J; Roca P; Dando I; Donadelli M
    Free Radic Biol Med; 2016 Dec; 101():305-316. PubMed ID: 27989750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
    Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
    Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic phenotype of bladder cancer.
    Massari F; Ciccarese C; Santoni M; Iacovelli R; Mazzucchelli R; Piva F; Scarpelli M; Berardi R; Tortora G; Lopez-Beltran A; Cheng L; Montironi R
    Cancer Treat Rev; 2016 Apr; 45():46-57. PubMed ID: 26975021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl.
    Mason EF; Zhao Y; Goraksha-Hicks P; Coloff JL; Gannon H; Jones SN; Rathmell JC
    Cancer Res; 2010 Oct; 70(20):8066-76. PubMed ID: 20876800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells.
    Straus DS
    Mol Cancer; 2013 Jul; 12():78. PubMed ID: 23866118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jolkinolide B induces apoptosis and inhibits tumor growth in mouse melanoma B16F10 cells by altering glycolysis.
    Gao C; Yan X; Wang B; Yu L; Han J; Li D; Zheng Q
    Sci Rep; 2016 Oct; 6():36114. PubMed ID: 27796318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-enriched solute carrier family 2 member 1 (SLC2A1/GLUT1) in psoriatic keratinocytes confers sensitivity to 2-deoxy-D-glucose (2-DG) treatment.
    Huang X; Chen J; Zeng W; Wu X; Chen M; Chen X
    Exp Dermatol; 2019 Feb; 28(2):198-201. PubMed ID: 30480843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.